Physician

Justin Kevin Dixon, M.D.

According to 2025 Medicare claims, Justin Dixon, M.D. (NPI: 1013182443) practices urology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1972830404; TIN: 264183569) and primary practice location at 41101-2843.

Dixon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 742 traditional Medicare patients, billed 2,095 HCPCS/CPT codes, and received $133,276 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,773 prescription claims across 847 beneficiaries totaling $797,690 in drug costs, led by Xtandi (Enzalutamide). DME data shows 20 claims. Open Payments data shows 25 records totaling $867. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $279,276 to $133,276. In contrast, Part D prescription costs have risen steadily, from $69,873 to $797,690. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	803	9,759	$279,276
2016	928	10,938	$285,984
2017	1,091	18,310	$280,668
2018	1,071	4,841	$231,784
2019	1,128	4,651	$257,816
2020	798	2,730	$164,368
2021	750	2,666	$179,779
2022	750	2,554	$171,009
2023	813	2,412	$166,087
2024	742	2,095	$133,276

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	324	1,031	$69,873
2016	393	1,595	$132,051
2017	517	1,858	$190,237
2018	580	2,236	$214,407
2019	653	2,434	$437,629
2020	630	2,316	$356,903
2021	576	1,812	$469,419
2022	608	1,736	$263,353
2023	718	2,023	$380,330
2024	847	2,773	$797,690

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$4,974
2016	N/R	47	$6,344
2017	N/R	26	$3,930
2018	N/R	29	$5,919
2019	12	87	$28,512
2020	14	75	$21,717
2021	N/R	64	$23,859
2022	N/R	35	$12,609
2023	N/R	15	$5,220
2024	N/R	20	$8,957

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	86	97	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	315	$65
52000	Diagnostic exam of bladder and urethra using an endoscope	141	158	$52
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	225	264	$45
81003	Automated urinalysis test	407	525	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	40	1,200	$575,032
Gemtesa	Vibegron	54	3,150	$49,317
Myrbetriq	Mirabegron	67	2,579	$38,041
Testosterone	Testosterone	105	3,907	$22,561
Xyosted	Testosterone Enanthate	20	928	$20,369

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	20	$8,957

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$867	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Justin Kevin Dixon, M.D.?

Tedicare shows public-source Medicare data for Justin Kevin Dixon, M.D. (NPI 1013182443), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Justin Kevin Dixon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Justin Kevin Dixon, M.D.?

Justin Kevin Dixon, M.D. is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1972830404) in the available physician profile data.

Does Justin Kevin Dixon, M.D. have Open Payments data?

Justin Kevin Dixon, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.